BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23140295)

  • 1. Targeting CSC-related miRNAs for cancer therapy by natural agents.
    Bao B; Li Y; Ahmad A; Azmi AS; Bao G; Ali S; Banerjee S; Kong D; Sarkar FH
    Curr Drug Targets; 2012 Dec; 13(14):1858-68. PubMed ID: 23140295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.
    Bao B; Azmi AS; Li Y; Ahmad A; Ali S; Banerjee S; Kong D; Sarkar FH
    Curr Stem Cell Res Ther; 2014 Jan; 9(1):22-35. PubMed ID: 23957937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.
    Bao B; Azmi AS; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Sarkar FH
    Biochim Biophys Acta; 2012 Dec; 1826(2):272-96. PubMed ID: 22579961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.
    Bao B; Ahmad A; Azmi AS; Ali S; Sarkar FH
    Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.25. PubMed ID: 23744710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
    Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of microRNAs in cancer and cancer stem cells.
    Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
    J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA regulation of cancer stem cells.
    Liu C; Tang DG
    Cancer Res; 2011 Sep; 71(18):5950-4. PubMed ID: 21917736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
    Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
    J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential.
    Bhardwaj A; Arora S; Prajapati VK; Singh S; Singh AP
    Curr Drug Targets; 2013 Sep; 14(10):1175-84. PubMed ID: 23834145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
    Ma Y; Shen N; Wicha MS; Luo M
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
    Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH
    Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.
    Mamoori A; Gopalan V; Smith RA; Lam AK
    Biol Cell; 2016 Mar; 108(3):51-64. PubMed ID: 26712035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.
    Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B
    Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.